Vaxcyte (PCVX)

• Market cap: $5.85B
• 1 day: -1.8%
• 5 days: -8.87%
• 1 month: 4.37%
• 3 months: 41.63%
• 6 months: 27.64%
• Year to date: -46.34%
• 1 year: -51.2%
• 5 years: 42.86%
• 10 years: 70.94%
• Sector: Healthcare
• Industry: Biotechnology

About: Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Employees: 414